FDA Commissioner Scott Gottlieb said the behavior of hindering other companies from making generic versions of blockbuster drugs is "gaming the system."
from Kaiser Health News https://ift.tt/2wStxVX
May 18, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Johnson & Johnson CEO Warns That Pharma Should Police Itself Over Drug Prices As Other Options Could Be ‘Onerous’“If we don’t do this as an industry, I think there will be other alternatives that will be more onerous for us,” Johnson & Johnson CEO Alex Gorsky said at the J.P. Morgan Healthcare Conference in California. Drug pricing … Read More
Flurry Of Movement On Capitol Hill On Drug Pricing May Signal Possible Rough Waters Ahead For PharmaSen. Chuck Grassley (R-Iowa) was one of a handful of lawmakers who have introduced legislation to curb high drug costs in the first few weeks of Congress being back in session. The topic is seen as one of only a few bipartisa… Read More
First Edition: January 10, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News http://bit.ly/2RiesqC … Read More
Innovative App Would Detect Opioid Overdoses, Developers Say. Would People Turn It On, Though?Researchers tested the experimental gadget at North America's first supervised injection site in Vancouver, British Columbia, and found it correctly identified breathing problems. Other news on the opioid crisis focuses on a … Read More
Some States Mull A Medicaid ‘Buy In’ As More Palatable Solution To Politically Polarizing ‘Medicare For All’ PlansStates have begun exploring the possibility of a Medicaid "buy in" as an attractive option for people who are struggling to find affordable coverage. With the strategy comes a plethora of questions, though, such as, who would… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment